Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 12.30
+0.44 (3.71%)
At close: Aug 21, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 176.54 million as of August 21, 2026. Its market cap has decreased by -67.20% in one year.
Market Cap
176.54M
Enterprise Value
170.86M
Revenue
n/a
Ranking
n/a
PE Ratio
20.28
Stock Price
12.30
ChartMarket Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 176.54M, an increase of 709.78%. That is a compound annual growth rate of 11.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 176.54M | -65.49% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.39B |
| Kimia Biosciences | 1.32B |
| Krebs Biochemicals & Industries | 1.17B |
| Tyche Industries | 1.07B |
| Vasundhara Rasayans | 489.44M |
| Crestchem | 373.05M |
| Alfavision Overseas (India) | 368.85M |
| Ishita Drugs and Industries | 228.88M |